Cubist Pharmaceuticals Inc. (CBST) Tops Q1 EPS by 27c

April 14, 2011 4:01 PM EDT
Cubist Pharmaceuticals Inc. (NASDAQ: CBST) reported Q1 EPS of $0.55, $0.27 better than the analyst estimate of $0.28. Revenue for the quarter came in at $162.5 million versus the consensus estimate of $155.78 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings